Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The following 3 trials received Green Light approval from OCTRU in February and are now open to recruitment:

 

GRASP -  A trial looking at the best treatments for shoulder pain in patients with a rotator cuff disorder. (Further information here)

TROMBONE – Testing Radical prostatectomy in men with oligoMetastatic prostate cancer that has spread to the bone (Further information here). 

OTTER 2 - A randomised controlled trial into the effectiveness and efficacy of splints in thumb based osteoarthritis. (Further information here)

 

Further news items will follow when first patients are recruited.

Similar stories

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.